FINWIRES · TerminalLIVE
FINWIRES

研究報告:CFRA 將美國航空集團股票評級從「買入」下調至「持有」。

-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點摘要如下:我們維持對AAL未來12個月的目標價為13美元,相當於2027年每股盈餘預期(不變)的6.5倍,低於10年平均水準8.5倍,反映出獲利風險上升。我們將2026年每股收益預期從0.74美元下調至0.48美元,並將2027年每股收益預期從1.98美元下調至1.93美元,主要原因是燃油成本上升,但強勁的需求和不斷提高的機票收益率部分抵消了這一影響。我們將評級從“買入”下調至“持有”,認為管理層預計燃油成本將增加40億美元,這對盈利構成重大不利因素。我們對AAL未來12個月每股收益的預期高於其2026年每股收益預期區間(-0.40美元至1.10美元)的中點,這反映出我們認為強勁的旅行需求和定價能力可以抵消燃油成本上升的影響。然而,我們認為風險/回報比仍然不利。儘管美國航空(AAL)展現出令人矚目的營收成長勢頭,第一季單位營收成長7.6%,大西洋航線營收成長16.7%,企業管理業務營收成長13%,但燃油成本上漲幅度巨大,導致獲利波動劇烈,難以透過價格或營運效率的提升完全抵銷。

Related Articles

Asia

Clinuvel Unlikely to Seek Scenesse's Vitiligo Approval Before Phase 3 Completion, Says Jefferies

Clinuvel Pharmaceuticals (ASX:CUV) is unlikely to seek regulatory approval for Scenesse in vitiligo until the Phase 3 CUV105 and CUV107 clinical trials are completed, according to a Friday Jefferies note.The company said on Friday that the European Medicines Agency (EMA) has proposed evaluating the company's Scenesse drug for the treatment of systemic vitiligo based on a "totality of evidence" regulatory approach.Jefferies said that the EMA's decision is a positive for the company because of the high unmet medical need for Vitiligo treatment.The investment firm has pushed back its revenue expectations from Scenesse in vitiligo, which is now expected to begin in the second half of fiscal 2029 rather than fiscal 2028.Jefferies kept a buy rating on Clinuvel and cut its price target to AU$39.20 from AU$40.50.

$ASX:CUV
Asia

ASX Preview: Australian Shares Set to Open Flat on Stalled US-Iran Talks; Origin Energy Reports Lower March Quarter Production

Australian shares are set to open flat on Monday, as oil prices climbed almost 2% following stalled US-Iran peace negotiations and restricted flows through the Strait of Hormuz, tightening global supply and pushing Brent crude above $107 a barrel.On April 25, the S&P 500 and the Nasdaq Composite rose 0.8% and 1.6%, respectively, while the Dow Jones Industrial Average fell 0.2%.In the macroeconomy, investors are eyeing the release of Australia's consumer price index report on Wednesday.In corporate news, Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.IperionX's (ASX:IPX) titanium powder production operations in Virginia, US, transitioned to an around-the-clock production schedule during the March quarter, advancing from commissioning to continuous operations, according to a Monday filing with the Australian bourse.Australia's benchmark index fell 0.1% or 6.9 points to close at 8,786.50 on April 24.

$^AXJO$ASX:IPX$ASX:ORG
Asia

Cobre Appoints Chief Financial Officer

Cobre (ASX:CBE) has appointed Kaveen Bachoo as chief financial officer, effective April 28, according to a Monday filing with the Australian bourse.Bachoo has over 20 years of finance leadership experience in the mining sector, including executive positions at Glencore.

$ASX:CBE
研究報告:CFRA 將美國航空集團股票評級從「買入」下調至「持有」。 | FINWIRES